Genelux Corporation (NASDAQ: GNLX) Stock Information | RedChip

Genelux Corporation (NASDAQ: GNLX) Listen to this Section


$2.03
-0.1000 ( -4.69% ) 60.6K

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Market Data


Open


$2.03

Previous close


$2.13

Volume


60.6K

Market cap


$69.39M

Day range


$2.02 - $2.16

52 week range


$1.60 - $30.44

Insider Ownership Transactions

Total Amount Purchased: -194,297.00 | $ -394,422.91

Date Type Amount Purchased Purchaser
2023-11-21 Sale -3541.00 Yu Yong
2023-10-26 Sale -5704.00 Szalay Aladar
2023-10-25 Sale -5200.00 Yu Yong
2023-10-25 Sale -49987.00 Szalay Aladar
2023-10-16 Sale -2452.00 Thomas John
2023-10-11 Sale -5200.00 Yu Yong
2023-10-10 Sale -13266.00 Szalay Aladar
2023-10-04 Sale -22000.00 Jewett Caroline
2023-10-04 Sale -75690.00 Szalay Aladar
2023-09-29 Sale -11257.00 Szalay Aladar

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 01, 2024
4 Insider transactions 1 Apr 24, 2024
4 Insider transactions 1 Apr 18, 2024
8-k 8K-related 54 Apr 09, 2024
8-k 8K-related 53 Apr 02, 2024
10-k Annual reports 102 Mar 29, 2024
8-k 8K-related 52 Feb 05, 2024
8-k 8K-related 14 Feb 02, 2024
4 Insider transactions 1 Dec 18, 2023
4 Insider transactions 1 Dec 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.